COMPLIVISE
All products
04Label Intelligence

COMPLIVISE Label

Compare more than documents. Manage the complete label lifecycle.

Launch app

CCDS v7.2 → regional label comparison

Section 4.4 Special warnings · 3 country labels in scope

  • SmPC — Germany, v4.1

    Warning paragraph absent; wording added in CCDS v7.2

    Update required

    Variation type IB · due 04 Sep

  • USPI — United States, v3.8

    Equivalent wording present under Warnings and Precautions

    Aligned — no change

    Verified by K. Rao

  • PIL — India, v2.4

    Patient-facing wording pending translation review

    Implementation overdue

    M. Shah · due 22 Aug

Differences are held at section level, with approval and effective dates per market. · Illustrative product experience.

How the work moves, end to end.

What enters
CCDS, SmPC, USPI, PIL and regional labels with version, effective and approval dates held in a structured repository.
What is assessed
Section-level difference detection across documents and countries, with label-impact assessment against the triggering change.
What action follows
Review and approval cycles, implementation tracking per market and downstream submission handoffs.
What evidence remains
Version history, section-level differences, approver identity, effective dates and closure records per country.

What it does.

  • CCDS comparison
  • SmPC comparison
  • USPI comparison
  • PIL comparison
  • Regional-label comparison
  • Section-level difference detection
  • Label repository
  • Country-specific labels
  • Version history
  • Effective and approval dates
  • Label-impact assessment
  • Review and approval
  • Implementation tracking
  • Closure evidence

Next layer

COMPLIVISE Quality

Simple quality management designed for pharmaceutical teams.

Explore Quality Intelligence